AbstractAim: The aim of the present study was to assess sensitivity and specificity of modified triple assessment indiagnosis of breast lump.Methods: The present study was conducted in the Department of General Surgery for the period of 2 years andrandomly selected 100 female patients with breast lump attending surgery OPD and admitted in female surgicalward surgical unit during the study period.Results: Mean age was 35.45 ± 12.78 years. Youngest patient was of 16 years of age and oldest patient was 70years of age. In present study the breast lump was present more on right side 56 patients as compared to left side44. As from present study we observed that most common size of lump was in range of >2 cm to 5 cm indiameter in clinical breast examination are 68 patients and in 32 patients, size of lump is more than 5 cm indiameter. Most of the patients who went under clinical breast examination yield that mostly the patients withlump in firm consistency 65 patients, 1 of them had soft and other 34 patients had hard in consistency. 80%patients had well circumscribed masswith regular margins followed by Density lesion with microcalcification,irregularmargins and speculation (10%). In the study, 43% patients had Fibroadenoma, 21% patients had Ductalcell carcinoma and 15% patients had Fibro adenosis. In FNAC, 64% patients had Fibroadenoma, 21% patientshad Fibroadenosis and 4% patients had cyst. The sensitivity was 90.62% and specificity was 100%, positivepredictive value was 100%, and negative predictive value was 96.74%. P value was significant (0.000).Conclusion: Modified triple assessment is a very useful diagnostic tool to evaluate patients with breast lumpsand to detect patients with breast cancers with an overall accuracy of 98%. Modified triple assessment wasuseful in diagnosing breast cancers at an earlier stage, with most of breast cancers detected at stage I or stage II(T1 or T2, N0 or N1, M0). It was found that triple assessment did not require hospitalization, but was performedon OPD basis, without any complications.

AbstractAim: The aim of the present study was to assess sensitivity and specificity of modified triple assessment indiagnosis of breast lump.Methods: The present study was conducted in the Department of General Surgery for the period of 2 years andrandomly selected 100 female patients with breast lump attending surgery OPD and admitted in female surgicalward surgical unit during the study period.Results: Mean age was 35.45 ± 12.78 years. Youngest patient was of 16 years of age and oldest patient was 70years of age. In present study the breast lump was present more on right side 56 patients as compared to left side44. As from present study we observed that most common size of lump was in range of >2 cm to 5 cm indiameter in clinical breast examination are 68 patients and in 32 patients, size of lump is more than 5 cm indiameter. Most of the patients who went under clinical breast examination yield that mostly the patients withlump in firm consistency 65 patients, 1 of them had soft and other 34 patients had hard in consistency. 80%patients had well circumscribed masswith regular margins followed by Density lesion with microcalcification,irregularmargins and speculation (10%). In the study, 43% patients had Fibroadenoma, 21% patients had Ductalcell carcinoma and 15% patients had Fibro adenosis. In FNAC, 64% patients had Fibroadenoma, 21% patientshad Fibroadenosis and 4% patients had cyst. The sensitivity was 90.62% and specificity was 100%, positivepredictive value was 100%, and negative predictive value was 96.74%. P value was significant (0.000).Conclusion: Modified triple assessment is a very useful diagnostic tool to evaluate patients with breast lumpsand to detect patients with breast cancers with an overall accuracy of 98%. Modified triple assessment wasuseful in diagnosing breast cancers at an earlier stage, with most of breast cancers detected at stage I or stage II(T1 or T2, N0 or N1, M0). It was found that triple assessment did not require hospitalization, but was performedon OPD basis, without any complications.